ici 169369 has been researched along with arginine vasopressin in 1 studies
| Studies (ici 169369) | Trials (ici 169369) | Recent Studies (post-2010) (ici 169369) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
|---|---|---|---|---|---|
| 31 | 4 | 0 | 12,278 | 422 | 1,212 |
| Protein | Taxonomy | ici 169369 (IC50) | arginine vasopressin (IC50) |
|---|---|---|---|
| Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baylis, PH; Jones, IR; Kendall-Taylor, P; Thompson, CJ; Walker, M | 1 |
1 trial(s) available for ici 169369 and arginine vasopressin
| Article | Year |
|---|---|
The effects of the specific serotonin antagonist ICI 169,369 on the pituitary hormone response to insulin-induced hypoglycaemia in humans.
Topics: Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Double-Blind Method; Drug Administration Schedule; Growth Hormone; Humans; Hypoglycemia; Male; Pituitary Gland; Pituitary Hormones; Prolactin; Quinolines; Serotonin Antagonists | 1992 |